Literature DB >> 21138846

Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming.

Ken Nishimura1, Masayuki Sano, Manami Ohtaka, Birei Furuta, Yoko Umemura, Yoshiro Nakajima, Yuzuru Ikehara, Toshihiro Kobayashi, Hiroaki Segawa, Satoko Takayasu, Hideyuki Sato, Kaori Motomura, Eriko Uchida, Toshie Kanayasu-Toyoda, Makoto Asashima, Hiromitsu Nakauchi, Teruhide Yamaguchi, Mahito Nakanishi.   

Abstract

The ectopic expression of transcription factors can reprogram differentiated tissue cells into induced pluripotent stem cells. However, this is a slow and inefficient process, depending on the simultaneous delivery of multiple genes encoding essential reprogramming factors and on their sustained expression in target cells. Moreover, once cell reprogramming is accomplished, these exogenous reprogramming factors should be replaced with their endogenous counterparts for establishing autoregulated pluripotency. Complete and designed removal of the exogenous genes from the reprogrammed cells would be an ideal option for satisfying this latter requisite as well as for minimizing the risk of malignant cell transformation. However, no single gene delivery/expression system has ever been equipped with these contradictory characteristics. Here we report the development of a novel replication-defective and persistent Sendai virus (SeVdp) vector based on a noncytopathic variant virus, which fulfills all of these requirements for cell reprogramming. The SeVdp vector could accommodate up to four exogenous genes, deliver them efficiently into various mammalian cells (including primary tissue cells and human hematopoietic stem cells) and express them stably in the cytoplasm at a prefixed balance. Furthermore, interfering with viral transcription/replication using siRNA could erase the genomic RNA of SeVdp vector from the target cells quickly and thoroughly. A SeVdp vector installed with Oct4/Sox2/Klf4/c-Myc could reprogram mouse primary fibroblasts quite efficiently; ∼1% of the cells were reprogrammed to Nanog-positive induced pluripotent stem cells without chromosomal gene integration. Thus, this SeVdp vector has potential as a tool for advanced cell reprogramming and for stem cell research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21138846      PMCID: PMC3039346          DOI: 10.1074/jbc.M110.183780

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  A fluorescent variant of a protein from the stony coral Montipora facilitates dual-color single-laser fluorescence cross-correlation spectroscopy.

Authors:  Takako Kogure; Satoshi Karasawa; Toshio Araki; Kenta Saito; Masataka Kinjo; Atsushi Miyawaki
Journal:  Nat Biotechnol       Date:  2006-04-30       Impact factor: 54.908

2.  Sendai virus RNA polymerase scanning for mRNA start sites at gene junctions.

Authors:  Philippe Plattet; Laura Strahle; Philippe le Mercier; Stéphane Hausmann; Dominique Garcin; Daniel Kolakofsky
Journal:  Virology       Date:  2007-02-14       Impact factor: 3.616

3.  Contribution of the leader sequence to homologous viral interference among Sendai virus strains.

Authors:  Yukie Shimazu; Shin-Ich Takao; Takashi Irie; Katsuhiro Kiyotani; Tetsuya Yoshida; Takemasa Sakaguchi
Journal:  Virology       Date:  2007-11-26       Impact factor: 3.616

4.  Persistent and stable gene expression by a cytoplasmic RNA replicon based on a noncytopathic variant Sendai virus.

Authors:  Ken Nishimura; Hiroaki Segawa; Takahiro Goto; Mariko Morishita; Akinori Masago; Hitoshi Takahashi; Yoshihiro Ohmiya; Takemasa Sakaguchi; Masahiro Asada; Toru Imamura; Kunitada Shimotono; Kozo Takayama; Tetsuya Yoshida; Mahito Nakanishi
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

Review 5.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

6.  Sendai virus gene expression in lytically and persistently infected cells.

Authors:  H E Homann; P H Hofschneider; W J Neubert
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

7.  Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.

Authors:  Mariko Yoshizaki; Takashi Hironaka; Hitoshi Iwasaki; Hiroshi Ban; Yumiko Tokusumi; Akihiro Iida; Yoshiyuki Nagai; Mamoru Hasegawa; Makoto Inoue
Journal:  J Gene Med       Date:  2006-09       Impact factor: 4.565

8.  Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.

Authors:  Yusuke Murakami; Yasuhiro Ikeda; Yoshikazu Yonemitsu; Sakura Tanaka; Haruhiko Kondo; Shinji Okano; Ri-Ichiro Kohno; Masanori Miyazaki; Makoto Inoue; Mamoru Hasegawa; Tatsuro Ishibashi; Katsuo Sueishi
Journal:  J Gene Med       Date:  2008-02       Impact factor: 4.565

9.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 10.  RNA interference against viruses: strike and counterstrike.

Authors:  Joost Haasnoot; Ellen M Westerhout; Ben Berkhout
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

View more
  133 in total

Review 1.  Generation of pluripotent stem cells without the use of genetic material.

Authors:  Akon Higuchi; Qing-Dong Ling; S Suresh Kumar; Murugan A Munusamy; Abdullah A Alarfaj; Yung Chang; Shih-Hsuan Kao; Ke-Chen Lin; Han-Chow Wang; Akihiro Umezawa
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662

Review 2.  Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.

Authors:  Marica Grskovic; Ashkan Javaherian; Berta Strulovici; George Q Daley
Journal:  Nat Rev Drug Discov       Date:  2011-11-11       Impact factor: 84.694

Review 3.  Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells.

Authors:  Andrew M Tidball; Jack M Parent
Journal:  Stem Cells       Date:  2015-09-15       Impact factor: 6.277

Review 4.  Present and future challenges of induced pluripotent stem cells.

Authors:  Mari Ohnuki; Kazutoshi Takahashi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-10-19       Impact factor: 6.237

Review 5.  Stem Cells in Skeletal Tissue Engineering: Technologies and Models.

Authors:  Mark T Langhans; Shuting Yu; Rocky S Tuan
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

6.  Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.

Authors:  C Bueno; J L Sardina; B Di Stefano; D Romero-Moya; A Muñoz-López; L Ariza; M C Chillón; A Balanzategui; J Castaño; A Herreros; M F Fraga; A Fernández; I Granada; O Quintana-Bustamante; J C Segovia; K Nishimura; M Ohtaka; M Nakanishi; T Graf; P Menendez
Journal:  Leukemia       Date:  2015-10-26       Impact factor: 11.528

7.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

Review 8.  Induced pluripotent stem cells: origins, applications, and future perspectives.

Authors:  Jing Zhao; Wen-jie Jiang; Chen Sun; Cong-zhe Hou; Xiao-Mei Yang; Jian-gang Gao
Journal:  J Zhejiang Univ Sci B       Date:  2013-12       Impact factor: 3.066

9.  Plastin 3 is upregulated in iPSC-derived motoneurons from asymptomatic SMN1-deleted individuals.

Authors:  Ludwig Heesen; Michael Peitz; Laura Torres-Benito; Irmgard Hölker; Kristina Hupperich; Kristina Dobrindt; Johannes Jungverdorben; Swetlana Ritzenhofen; Beatrice Weykopf; Daniela Eckert; Seyyed Mohsen Hosseini-Barkooie; Markus Storbeck; Noemi Fusaki; Renata Lonigro; Raoul Heller; Min Jeong Kye; Oliver Brüstle; Brunhilde Wirth
Journal:  Cell Mol Life Sci       Date:  2015-11-16       Impact factor: 9.261

10.  GPAT2, a mitochondrial outer membrane protein, in piRNA biogenesis in germline stem cells.

Authors:  Yusuke Shiromoto; Satomi Kuramochi-Miyagawa; Akito Daiba; Shinichiro Chuma; Ami Katanaya; Akiko Katsumata; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Toshinobu Nakamura; Koichi Yoshinaga; Noriko Asada; Shota Nakamura; Teruo Yasunaga; Kanako Kojima-Kita; Daisuke Itou; Tohru Kimura; Toru Nakano
Journal:  RNA       Date:  2013-04-23       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.